skip to main content

S. 2465: Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018

A bill to amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and to provide for sickle cell disease research, surveillance, prevention, and treatment.

The bill’s titles are written by its sponsor.

Sponsor and status

Tim Scott

Sponsor. Junior Senator for South Carolina. Republican.

Read Text »
Last Updated: Aug 15, 2018
Length: 14 pages
Introduced:

Feb 28, 2018

Status:

Ordered Reported on Jul 25, 2018

The committees assigned to this bill sent it to the House or Senate as a whole for consideration on July 25, 2018.

Prognosis:

21% chance of being enacted according to Skopos Labs (details)

History

Feb 28, 2018
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Jul 25, 2018
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Pending
 
Passed Senate (House next)

Pending
 
Passed House

Pending
 
Signed by the President

S. 2465 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 2465 — 115th Congress: Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018.” www.GovTrack.us. 2018. September 19, 2018 <https://www.govtrack.us/congress/bills/115/s2465>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.